Nitric oxide: Link between endothelial dysfunction and inflammation in patients with peripheral arterial disease of the lower limbs

Interactive Cardiovascular and Thoracic Surgery

Volumn 9, Issue 1, 2009, Pages 107-112

  De Haro Miralles, Joaquin ^a,b   Martínez Aguilar, Esther ^a   Florez, Aurora ^a   Varela, César ^a   Bleda, Silvia ^a   Acin, Francisco ^a  

^a HOSPITAL UNIVERSITARIO DE GETAFE   (Spain)

^b NONE   (Spain)

Author keywords

Endothelial dysfunction; Inflammation; Nitric oxide; Peripheral arterial disease

Indexed keywords

C REACTIVE PROTEIN; NITRIC OXIDE;

ADULT; AGED; ARTERY DILATATION; ARTERY DISEASE; BRACHIAL ARTERY; COLORIMETRY; CONFERENCE PAPER; CONTROLLED STUDY; ENDOTHELIAL DYSFUNCTION; FEMALE; HEART HEMODYNAMICS; HUMAN; LEG ISCHEMIA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BRACHIAL ARTERY; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; DISEASE PROGRESSION; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; INFLAMMATION; ISCHEMIA; LOWER EXTREMITY; MALE; MIDDLE AGED; NITRIC OXIDE; NITRITES; PERIPHERAL VASCULAR DISEASES; SEVERITY OF ILLNESS INDEX; UP-REGULATION; VASODILATION;

EID: 67650156439     PISSN: 15699293     EISSN: None     Source Type: Journal    
DOI: 10.1510/icvts.2008.196428     Document Type: Conference Paper

References (25)

1. Ignarro LJ, Cirino G, Casini A, Napoli C. Nitric oxide as a signalling molecule in the vascular system: an overview. J Cardiovasc Pharmacol 1999;34:879-886.
2. Kleinbongard P, Dejam A, Lauer T, Rassaf T, Schindler A, Picker O. Plasma nitrite reflects constitutive nitric oxide synthase activity in mammals. Free Radic Biol Med 2003;35:1551-1559. (Pubitemid 37329482)
3. Berry KL, Skyrme-Jones AP, Meredith IT. Occlusion cuff position is an important determinant of the time course and magnitude of human brachial artery flow-mediated dilation. Clin Sci 2000;99:261-267. (Pubitemid 30795863)
4. Pepys MB, Hirschfield GM. C-reactive protein: a critical update. J Clin Invest 2003;111:1805-1812.
5. Verma S, Wang CH, Li SH, Dumont AS, Fedak PW, Badiwala MV. A selffulfilling prophecy: C-reactive protein attenues nitric oxide production and inhibits angiogenesis. Circulation 2002;106:913-919. (Pubitemid 34925323)
6. De Haro J, Acin F, Lopez-Quintana A, Medina FJ, Martinez-Aguilar E, Florez A, March JR. Direct association between C-reactive protein serum levels and endothelial dysfunction in patients with claudication. Eur J Vasc Endovasc Surg 2008;35:480-486. (Pubitemid 351296162)
7. Medina-Maldonado FJ, Martínez-Aguilar E, De Haro-Miralles J, Flórez-González A, March-García JR, Acín F. Disfunción endotelial medida en los miembros inferiores de pacientes con arteriopatía periférica. Angiologia 2007;59:237-244. (Pubitemid 351737942)
8. Kleinbongard P, Rassaf T, Dejam A, Kerber S, Kelm M. Griess method for nitrite measurement of aqueous and protein containing sample. Methods Enzymol 2002;359:158-168. (Pubitemid 35387018)
9. Eda S, Kaufmann J, Roos W, Pohl S. Development of a new microparticleenhanced turbidimetric assay for C-reactive protein with superior features in analytical sensitivity and dynamic range. J Clin Lab Anal 1998;12:137-144. (Pubitemid 28208752)
10. Medina F, De Haro J, Martínez E, Florez A, March JR, Acín F. Relationship between non-invasively measured endothelial function and peripheral arterial disease. Angiology first published on December 2, 2008 as doi: 10.1177y0003319708327787.
11. Schmieder JS. Impaired endothelial function in arterial hypertension and hypercholesterolemia potential mechanisms and differences. J Hypertension 2000;18:363-374. (Pubitemid 30209715)
12. Shivalkar B, Dhondt D, Goovaerts I, Van Gaal L, Bartunek J, Van Crombrugge. Flow mediated dilatation and cardiac function in type 1 diabetes mellitus. Am J Cardiol 2006;97:77-82. (Pubitemid 41828127)
13. Yu H-I, Sheu WH-H, Lai C-J, Lee W-J, Chen Y-T. Endothelial dysfunction in type 2 diabetes mellitus subjects with peripheral artery disease. Int J Cardiol 2001;78:19-25. (Pubitemid 32232133)
14. Celermajer DS, Sorensen K, Georgakopoulos D, Bull C, Thomas O, Robinson J. Cigarette smoking is associated with dose-related and potentially reversible impairment of endothelium-dependent dilation in healthy young adults. Circulation 1993;88:2149-2155. (Pubitemid 23326094)
15. Brevetti G, Silvestro A, Di Giacomo S, Bucur R, Di Donato A, Schiano V. Endothelial dysfunction in peripheral arterial disease is related to increase in plasma markers of inflammation and severity of peripheral circulatory impairment but not to classic risk factors and atherosclerosis burden. J Vasc Surg 2003;38:374-379. (Pubitemid 41123265)
16. Gokce N, Keaney Jr JF, Hunter LM, Watkins MT, Nedeljkovic ZS, Menzoian JO. Predictive value of non-invasively determined endothelial dysfunction for long-term cardiovascular events in patients with peripheral vascular disease. J Am Coll Cardiol 2003;41:1769-1775. (Pubitemid 36584251)
17. Barbato JE, Tzeng E. Nitric oxide and arterial disease. J Vasc Surg 2004;40:187-193.
18. Miyoshi T, Li Y, Shih DM, Wang X, Laubach VE, Matsumoto AH. Deficiency of inducible NO synthase reduces advanced but not early atherosclerosis in apolipoprotein E-deficient mice. Life Sci 2006;79:525-531. (Pubitemid 43913209)
19. Anderson TJ. Nitric oxide, atherosclerosis and the clinical relevance of endothelial dysfunction. Heart Fair Rev 2003;8:71-86. (Pubitemid 36342291)
20. Gunnet CA, Lund DD, McDowell AK, Faraci FM, Heistad DD. Mechanisms of inducible nitric oxide synthase-mediated vascular dysfunction. Arterioscler Thromb Vasc Biol 2005;25:1617-1622. (Pubitemid 41098930)
21. Boulanger FC, Tanner FC, Béa ML, Hahn AW, Werner A, Lüscher TF. Oxidized low density lipoproteins induce mRNA expression and release of endothelin from human and porcine endothelium. Circ Res 1992;70: 1191-1197.
22. Lerman A, Holmes D, Bell M. Endothelin in coronary endothelial dysfunction and early atherosclerosis in humans. Circulation 1995;92: 2426-2431.
23. Winkles JA, Alberts GF, Brogi E, Libby P. Endothelin-1 and endothelin receptor mRNA expression in normal and atherosclerotic human arteries. Biochem Biophys Res Commun 1993;191:1081-1088. (Pubitemid 23231600)
24. Lerman A, Edwards BS, Hallet JW, Heublein DM, Sandberg SM, Burnett JC. Circulating and tissue endothelin inmunoreactivity in advanced atherosclerosis. N Engl J Med 1991;325:997-1001.
25. Clapp BR, Hirschfield GM, Storry C, Gallimore JR, Stidwill RP, Singer M. Inflammation and endothelial function. Direct vascular effects of human C-reactive protein on nitric oxide bioavailability. Circulation 2005;111: 1530-1536.